Innoviva Stock Price

-0.08 (-0.66%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Innoviva Inc INVA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.08 -0.66% 12.01 11:03:04
Open Price Low Price High Price Close Price Prev Close
12.14 11.949 12.21 12.09
Bid Price Ask Price Spread News
12.00 12.03 0.03 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
444 37,423 $ 12.08 $ 452,161 700,063 9.21 - 15.69
Last Trade Time Type Quantity Stock Price Currency
11:02:55 100 $ 12.01 USD

Innoviva Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.22B 101.39M 57.64M $ 261.02M $ 231.86M 1.43 6.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Innoviva News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical INVA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week11.8512.2111.6211.95297,0930.161.35%
1 Month11.6012.8611.3911.94462,6330.413.53%
3 Months12.2312.9010.9211.90542,443-0.22-1.8%
6 Months9.7313.069.2111.53616,5982.2823.43%
1 Year13.3315.699.2112.24655,888-1.32-9.9%
3 Years16.1020.547.5813.72750,916-4.09-25.4%
5 Years13.7020.547.5813.34794,078-1.69-12.34%

Innoviva Description

Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes RELVAR/BREO/ELLIPTA, ANORO, ELLIPTA, TRELEGY, ELLIPTA, and others. The firm collaborates with and receives funding from GlaxoSmithKline.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.